000 | 01172 a2200349 4500 | ||
---|---|---|---|
005 | 20250511223502.0 | ||
264 | 0 | _c19910212 | |
008 | 199102s 0 0 eng d | ||
022 | _a0735-7907 | ||
024 | 7 |
_a10.3109/07357909009012071 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMahjoubi, M | |
245 | 0 | 0 |
_aPhase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer. _h[electronic resource] |
260 |
_bCancer investigation _c1990 |
||
300 |
_a477-81 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesna _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aSurvival Analysis |
700 | 1 | _aAzab, M | |
700 | 1 | _aGhosn, M | |
700 | 1 | _aTheodore, C | |
700 | 1 | _aDroz, J P | |
773 | 0 |
_tCancer investigation _gvol. 8 _gno. 5 _gp. 477-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/07357909009012071 _zAvailable from publisher's website |
999 |
_c2131092 _d2131092 |